Transparency Market Research
Cardiac Troponin Market Size to be Worth USD 11.5 billion by 2034, Growing at CAGR of 8.9% | Exclusive Report by Transparency Market Research, Inc.
16. Juli 2024 08:40 ET | Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research Inc. - , July 16, 2024 (GLOBE NEWSWIRE) -- The global cardiac troponin market (Markt für kardiales Troponin) stood at US$ 4.5...
Transparency Market Research
Gastrointestinal Pathogen Testing Market Size to be Worth USD 5.2 billion by 2031, with Notable CAGR of 3.2%| Transparency Market Research, Inc.
02. Januar 2024 09:00 ET | Transparency Market Research
Wilmington, Delaware, United States, Jan. 02, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The gastrointestinal pathogen testing industry was worth US$ 4.0 billion in 2022. A CAGR of...
MicrosoftTeams-image (5).png
Global In Vitro Diagnostics Market Demand will Reach a Value of US$ 115.43 Billion by the year 2028, at a CAGR of 6.3% | Data Analysis by Transparency Market Research
07. April 2023 10:00 ET | Transparency Market Research
Wilmington, Delaware, United States, April 07, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. – According to research, the global in vitro diagnostics market was worth US$ 70.51 Bn in...
Contrive Datum Insights_Logo.jpg
In Vitro Cancer Diagnostics Market Is Expected To Grow at a CAGR Of 3.9% during Forecast Period 2023 To 2030 | Data By Contrive Datum Insights Pvt Ltd.
13. Januar 2023 13:07 ET | Contrive Datum Insights Pvt Ltd
Farmington, Jan. 13, 2023 (GLOBE NEWSWIRE) -- The Global In-vitro Cancer Diagnostic Market is expected to grow at a CAGR of 3.9% during the forecasting period 2023-2030. Cancer is the growth of...
Medi Tech Insights Logo.jpg
Global Point-of-Care (POC) Blood Diagnostics Market is set to witness a growth rate of 6% by 2026 – Increasing Occurrence of Cardiovascular & Infectious Diseases
16. August 2022 09:30 ET | Medi-Tech Insights
BRUSSELS, BELGIUM, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Description: Point-of-care (POC) testing entails performing a diagnostic test outside of a laboratory, or near a patient and at the site where...
researchdrivelogo.jpg
Global Coagulation Testing Market Anticipated to Garner a Revenue of $3,566.0 Million at a CAGR of 5.9% during the Forecast Period, 2019-2026 - Absolute Report [Pages-105] by Research Dive
15. Juni 2021 09:15 ET | Research Dive
New York, USA, June 15, 2021 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global coagulation testing market is projected to register a revenue of $3,566.0  million at a...
Emergen logo.png
Patient Registry Software Market Size to Reach USD 2.96 Bn by 2027 | Rising Incidence of Chronic Diseases and Increasing Initiatives Related to Value-Based Care will be the Key Factor Driving the Industry Growth, States Emergen Research
26. Januar 2021 14:00 ET | Emergen Research
Vancouver, British Columbia, Jan. 26, 2021 (GLOBE NEWSWIRE) -- The global patient registry software market is forecast to reach a value of USD 2.96 Billion by 2027, at a rapid and steady CAGR of...
OptimizeRx.png
OptimizeRx Launches AI-Powered Real-World Evidence Solution on Its Point-of-Care Platform
01. Dezember 2020 07:31 ET | OptimizeRx Corporation
ROCHESTER, Mich., Dec. 01, 2020 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, has...
Cue_Logo.png
Cue Health Receives FDA Emergency Use Authorization for Its Rapid, Portable, Molecular Point-of-Care COVID-19 Test
12. Juni 2020 08:00 ET | Cue Health Inc.
SAN DIEGO, June 12, 2020 (GLOBE NEWSWIRE) -- Cue Health Inc. (“Cue”), a healthcare technology company, announced today that it has received Emergency Use Authorization (“EUA”) from the U.S. Food and...
2019_10_18 Sense Logo - 2 colour - RGB - transparent.png
Sense Appoints John Bishop to its Board of Directors
21. April 2020 02:00 ET | Sense Biodetection
Former Cepheid CEO joins as company launches an accelerated program for the world’s first instrument-free molecular test for COVID-19 CAMBRIDGE and OXFORD, UNITED KINGDOM, April 21, 2020 (GLOBE...